Perrigo Company plc Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities
Perrigo Company plc (PRGO) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities of $0 as of 2015-12-15, per its 10-Q filed 2016-11-10.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) › Business Combination, Recognized Liability Assumed, Liability › Business Combination, Recognized Liability Assumed, Liability, Noncurrent
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities · last filed 2016-11-10
- 2015-12-15: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities $0.00.
- 2015-09-15: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities $0.00.
- 2015-08-28: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities $0.00.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities |
|---|---|
| 2015-12-15 | $0.00 10-Q · filed 2016-11-10 |
| 2015-09-15 | $0.00 10-Q · filed 2016-11-10 |
| 2015-08-28 | $0.00 10-Q · filed 2016-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |